Logo Image
|Videos|October 28, 2016

National Prevalence of Multidrug-Resistant Organisms

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, discusses his research on the national prevalence of multidrug-resistant organisms.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, discusses his research on the national prevalence of multidrug-resistant organisms.

Interview Transcript (slightly modified for readability)

“We studied several organisms; we studied multidrug-resistant Enterobacteriaceae, multidrug-resistant Acinetobacter, multidrug-resistant Pseudomonas, [and] ESBL, or extended-spectrum β-lactamase-producing organisms as well. We studied these because, as many of you are familiar with the 2013 CDC Antibiotic Threat Report, these organisms were categorized as urgent or serious threats, and it’s one of the reasons why we really selected these organisms, to get an idea of how much is really out there in the overall healthcare setting.”

Related to this article

View more
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Read more
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Read more